ATOSbenzinga

Atossa Therapeutics Releases Preliminary Analysis From Phase 2 Trial Of (Z)-endoxifen As Part Of I-SPY 2 Endocrine Optimization Pilot Will Be Subject Of Poster Presentation At Inaugural RISE UP Breast Cancer Conference

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on October 31, 2024 by benzinga